Skip to content
healthcare.dev
Get a free key

ORSERDU

NDC 72187-0102, Elacestrant, tablet, film coated, from Stemline Therapeutics, Inc..

Product NDC
72187-0102
Status
Listed
Labeler
Stemline Therapeutics, Inc.
Dosage form
TABLET, FILM COATED
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
NDA
Application
NDA217639
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/72187-0102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • ELACESTRANT345 mg/1

Pharmacologic classes

Breast Cancer Resistance Protein Inhibitors [MoA]; Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; P-Glycoprotein Inhibitors [MoA]

Package NDCNDC-11Package
72187-0102-37218701020330 TABLET, FILM COATED in 1 BOTTLE (72187-0102-3)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/aa66ae5c-2bd2-4444-8178-b55651e054ef

Use it

Look up 72187-0102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/72187-0102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 72187-0102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.